We aspire to become a globally integrated biopharmaceutical company by leveraging our differentiated pipeline and proprietary R&D platforms.
For detailed information about our CMC and manufacturing capabilities, please refer to our subsidiary, Foster Bio, an independently operated CDMO service provider.You can visit Foster Bio's website: http://www.fosterbio.com/
